Compound or tautomeric form, pharmaceutically acceptable salt or solvate thereof, pharmaceutical composition, process for treating or preventing a disease, risk factor or condition, mediated by hppar alpha and / orhppar gamma, and use of a compound

摘要

"COMPOUND OR TAUTOMERIC FORM, PHARMACEUTICALLY ACCEPTABLE OUSOLVATO SALT OF THE SAME, PHARMACEUTICAL COMPOSITION, PROCESS FOR THE TREATMENT OR PREVENTION OF A DISEASE, RISK OR CONDITION FACTOR, MEASURED BY HPPAR ALPHA AND / OR HPPAR AND / OR HPPAR AND / OR HPPAR. The present invention describes compounds of formula (I), and pharmaceutically acceptable salts or solvates thereof. Preferably, the compounds of the invention consist of dual activators of hPPARy and hPPAR 244.